The creation of seizure-prone (Fast) and seizure-resistant (Slow) rat strains via selective breeding implies genetic control of relative seizure vulnerability, yet ample data also advocates an environmental contribution. To investigate potential environmental underpinnings to the differential seizure sensitivities in these strains, the authors compared amygdala kindling profiles in adult male Fast and Slow rats raised by (a) their own mother, (b) a foster mother from the same strain, or (c) a foster mother from the opposing strain. Ultimately, strain-specific kindling profiles were not normalized by cross-fostering. Instead, both strains became more seizure-prone regardless of maternal affiliation (i.e., cross-fostered groups from both strains kindled faster than uncrossed controls). Interhemispheric seizure spread was also facilitated in cross-fostered Slow rat groups and was associated with increased commissural cross-sectional areas, giving them a Fast-like profile. It is important to note, however, that all Fast groups remained significantly more seizure-prone than Slow groups, suggesting that although the postnatal environment strongly influenced seizure disposition in both strains, it did not wholly account for their relative dispositions. Investigation into mechanisms fundamental to cross-fostering-induced seizure facilitation should help prevent postnatal worsening of pathology in already seizure-prone individuals.
The incidence of obesity has nearly doubled in the last 30 years, and this rise in incidence is directly linked to increased consumption of energy-dense foods. In addition, the majority of people attempting to lose weight report relapse to high fat foods while dieting. Recent studies suggest that the orexigenic hormone ghrelin can bind to dopaminergic cells in the ventral tegmental area (VTA), a key structure in the brain's reward system, and increase the incentive value of such foods. Specifically, studies have shown that ghrelin increases the motivation to work for food rewards, enhances the preference for contexts associated with food rewards, and augments the locomotor and physiological responses associated with food rewards. The experiments described in the present thesis aimed to establish the role of ghrelin in 2 additional reward-based feeding behaviours thought to contribute to the current obesity epidemic. The first behaviour is the consumption of palatable desserts after meals that adequately satisfy an individual's energetic demands. The second behaviour is the tendency to relapse to food seeking after a period of abstinence. In order to accomplish this, we compared ghrelin receptor knock out (KO) rats to rats possessing an identical genetic background, with an intact ghrelin receptor gene (wildtype rats -WT) in tasks designed to model these behaviours. In addition, we examined outbred rats receiving chronic infusions of either ghrelin or a ghrelin receptor antagonist in the VTA. Overall, the data presented in this thesis confirmed the role of ghrelin signalling in dessert consumption; KO rats ate less cookie dough when sated than WT rats. KO and WT rats performed similarly in operant conditioning and conditioned place preference models of relapse, also known as the operant and CPP reinstatement tests. In contrast, pharmacological action at the ghrelin ! iii! receptor in outbred rats could enhance and attenuate the expression of reinstatement of food seeking that is induced by food reward cues following administration of ghrelin and a ghrelin receptor antagonist, respectively. It is therefore likely that ghrelin is involved in the tendency to relapse to unhealthy eating habits in dieting individuals, and that this effect is due, in part, to its action in the reward system, particularly within the VTA. ! iv!
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.